Adrx, Inc. reported raising $2.58 Million in an initial SEC Form D filing, from an offering of $2.58 Million
Amount Raised
$2.58 Million
Round Type
Seed
Quick answer
ADRX, Inc. raised $2.58 Million in a Seed round, dated October 2, 2020. ADRX, Inc. is based in Thousand Oaks, California, United States.
- How much did ADRX, Inc. raise?
- ADRX, Inc. raised $2.58 Million in a Seed round on October 2, 2020.
- What does ADRX, Inc. do?
- ADRx is advancing drug candidates for Alzhiemer’s disease, systemic amyloidosis and ovarian cancer.
- Where is ADRX, Inc. based and how big is it?
- ADRX, Inc. is based in Thousand Oaks, California, United States.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as ADRX, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Rani Therapeutics raised $50M on November 16, 2020.
- ProMIS Neurosciences raised $63K on November 16, 2020.
- Mammogen, Inc. raised $25K (Pre-Seed) on November 16, 2020.
- NovAccess Global Inc. raised $175K (Pre-Seed) on November 16, 2020.
- Polaris Genomics raised $75K on November 16, 2020.
- Aulos Bioscience, Inc. raised $15M on November 16, 2020.
Who to call at ADRX, Inc., and when
A new round usually means ADRX, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day ADRX, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ADRX, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ADRX, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ADRX, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
ADRX, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.